Hot Investor Mandate: Seed Fund With US and China Offices Seeks to Invest in All Global Life Science Technologies With a Strong Focus on Diagnostics and Digital Health

31 Mar

An early-stage venture capital firm with offices in USA and China has 2 business practices; managing a seed fund that invests exclusively in healthcare and life sciences, and an advisory business primarily for western biotech or life science companies that are looking to establish business opportunities and partnerships in greater China. The firm is starting to expand their network into the Middle East, especially Turkey. The firm is looking for Seed opportunities but is open to participation in Pre-Seed and Series A on a case by case basis. The typical check size is $50-250K in the form of equity or convertible notes. The firm will consider opportunities anywhere in the world.

The firm will look at all subsectors and indications but is not investing in immunotherapy or cancer at this time. The firm is particularly interested in chronic disease, especially diabetes and is starting to look at neurodegenerative diseases as well.  The firm is not doing biotech deals, but they’ve done deals in Healthcare IT and the AI space. The firm is focusing on diagnostics and digital health at the moment.

The firm is open to all management teams but prefers teams with prior start-up experience. The firm is not looking to do small participations in big rounds and would prefer to do investments where their stake has a meaningful impact on the company.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: